Funding
← Back to your selection

Polaris Partners

Activity from announced rounds

Activity in this selectionOct 17, 2026 · Jul 20, 2026
Rounds participated in
2
Confirmed lead rounds
0
All roles disclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$172.3M
2 disclosed · full round size, not this investor’s share

By stage

Series B2

By primary sector

Biotech1
Healthtech1

By country

United States2

Rounds

2 in this selection
Soufflé Therapeutics

Soufflé Therapeutics develops targeted RNA medicines for patients with muscle disorders and heart failure.

$135MSeries B
Participant
Faro AI

Structured data and AI agents for clinical development and pharmaceutical trial operations.

$37.3MSeries B
Participant